Plasmid-mediated quinolone resistance: an update
References (297)
- et al.
Quinolone resistance from a transferable plasmid
Lancet
(1998) - et al.
Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005
Clin Microbiol Infect
(2006) - et al.
The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition
J Mol Biol
(2001) - et al.
Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids
Clin Microbiol Infect
(2006) - et al.
In vitro mutagenesis of qnrA and qnrS genes and quinolone resistance in Escherichia coli
Clin Microbiol Infect
(2007) - et al.
Effects of a plasmid-encoded qnrA1 determinant in Escherichia coli strains carrying chromosomal mutations in the acrAB efflux pump genes
Diagn Microbiol Infect Dis
(2008) - et al.
The worldwide emergence of plasmid-mediated quinolone resistance
Lancet Infect Dis
(2006) - et al.
Plasmid-mediated quinolone resistance determinant qnrS in Enterobacter cloacae
Clin Microbiol Infect
(2006) Quinolone generations: natural history or natural selection?
J Antimicrob Chemother
(2000)- et al.
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use
Drugs
(1988)
Emergence and dissemination of quinolone-resistant Escherichia coli in the community
Antimicrob Agents Chemother
(1999)
Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use
JAMA
(2003)
Plasmid-mediated quinolone resistance: a multifaceted threat
Clin Microbiol Rev
(2009)
Mechanism of quinolone action and bacterial killing
Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance
Clin Infect Dis
(1998)
DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance
Proc Natl Acad Sci USA
(1997)
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Nat Med
(2006)
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli
Antimicrob Agents Chemother
(2007)
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate
Antimicrob Agents Chemother
(2007)
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan
Antimicrob Agents Chemother
(2008)
Quinolones in 2005: an update
Clin Microbiol Infect
(2005)
1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents
J Med Pharm Chem
(1962)
Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features
Expert Opin Pharmacother
(2001)
Review of the in vitro activity of gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens
J Antimicrob Chemother
(2000)
The in vitro activity of BMS-284756, a new des-fluorinated quinolone
J Antimicrob Chemother
(2002)
DNA gyrase, topoisomerase IV, and the 4-quinolones
Microbiol Mol Biol Rev
(1997)
DNA topoisomerases: structure, function, and mechanism
Annu Rev Biochem
(2001)
Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claims
J Antimicrob Chemother
(2002)
Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones
Mutagenesis
(1990)
Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives
J Antimicrob Chemother
(1986)
Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa
Antimicrob Agents Chemother
(1990)
Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital
Antimicrob Agents Chemother
(1989)
Clinical isolate of Citrobacter freundii highly resistant to new quinolones
Antimicrob Agents Chemother
(1988)
Ciprofloxacin resistance in Gram negative bacilli. Epidemiologic aspects
Enferm Infecc Microbiol Clin
(1993)
In vitro emergence of quinolone-resistant mutants of Escherichia coli Enterobacter cloacae, and Serratia marcescens
Antimicrob Agents Chemother
(1990)
Resistance to levofloxacin, failure of treatment of pneumococcal pneumonia
N Engl J Med
(2002)
Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations
Antimicrob Agents Chemother
(2001)
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Antimicrob Agents Chemother
(1990)
Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitro
Antimicrob Agents Chemother
(1994)
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus
Antimicrob Agents Chemother
(1996)
Routes of quinolone permeation in Escherichia coli
Antimicrob Agents Chemother
(1988)
Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production
Antimicrob Agents Chemother
(2002)
Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes
Antimicrob Agents Chemother
(1999)
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump
Antimicrob Agents Chemother
(2000)
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction
Antimicrob Agents Chemother
(1989)
Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants
J Antimicrob Chemother
(2005)
Qnr-like pentapeptide repeat proteins in Gram-positive bacteria
J Antimicrob Chemother
(2008)
Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants
BMC Microbiol
(2008)
Smaqnr, a new chromosome-encoded quinolone resistance determinant in Serratia marcescens
J Antimicrob Chemother
(2010)
Mechanism of plasmid-mediated quinolone resistance
Proc Natl Acad Sci USA
(2002)
Cited by (245)
Understanding mastitis: Microbiome, control strategies, and prevalence – A comprehensive review
2024, Microbial PathogenesisCurrent updates on green synthesis and biological properties of 4-quinolone derivatives
2023, Journal of Molecular StructureHigh prevalence of qnrVC variants in Vibrio spp. isolated from food samples in South China
2023, Microbiological Research
Copyright © 2011 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.